HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) (BSE: 500124) (NSE:DRREDDY) today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2015 under International Financial Reporting Standards (IFRS).
FY15: Key Highlights
•Three NDAs filed in our Proprietary Products business.
Help employers find you! Check out all the jobs and post your resume.
FY15: Key Highlights
•Three NDAs filed in our Proprietary Products business.
Help employers find you! Check out all the jobs and post your resume.
